4d Pharma News Today

A listed pharmaceutical company has called in administrators following an unsuccessful fundraise.

31.03.2022 - 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today reported financial results for the full year ending December ... Seite 1

4D pharma plc (NASDAQ:LBPS – Get Rating) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 38,500 shares, a growth of 3,108.3% from the February 28th total of 1,200 shares. Based on an average daily trading volume, of 352,500 shares, the days-to-cover ratio is currently 0.1 […]

4D pharma plc (LON:DDDD – Get Rating) shares were up 1% during mid-day trading on Friday . The company traded as high as GBX 54.90 ($0.72) and last traded at GBX 50.50 ($0.66). Approximately 5,496,229 shares changed hands during mid-day trading, an increase of 71% from the average daily volume of 3,219,667 shares. The stock […]

4D pharma plc (NASDAQ:LBPS – Get Rating) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,200 shares, a decline of 42.9% from the February 13th total of 2,100 shares. Based on an average daily volume of 12,100 shares, the days-to-cover ratio is […]